Lupin Shares Hit 52-Week High on Business Transfer Agreement With Subsidiary
Lupin shares hit a 52-week high of Rs 1,174.50 during the trading session on the NSE on 12 September, which came a day after the...
Tag : Lupin
Lupin Acquired Ondero & Ondero – Met for Rs 235 Crore
On Friday, 18 August, the Global pharma major Lupin Limited announced that it has acquired Ondero & Ondero – Met, a German brand from Boehringer...
Lupin Receives Approvals for Multiple New Drugs; Shares Hit 52-Week High
On 17 August, shares of Lupin Ltd hit a new 52-week high of Rs 1,143.95 on NSE after the company announced that it had received...
Lupin gets Approval from USFDA for Birth-Control Pills
Lupin received approval from the US Food and Drug Administration for manufacturing and marketing Turqoz, a genetic equivalent of the pregnancy prevention pill Lo/Ovral-28. The...
Lupin Receives Tentative Approval from USFDA for HIV Drug
Global pharma major Lupin Limited has received tentative approval from the US Food and Drug Administration for its new drug application for Dolutegravir Lamivudine and...
Lupin Receives Approval from USFDA for Chlorpromazine Hydrochloride Tablets; Shares Gain on Approval
On July 14, Lupin announced that its subsidiary, Lupin Inc, which is based in Somerset, New Jersey, had received a nod from United States Food...
Lupin Share Hits Fresh 52-week High after Getting USFDA Nod for key respiratory drug
Generic drugmaker Lupin Ltd announced that it had received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA)...
Lupin Shares Records 52-week High Post Launching Darunavir Tablets
On June 5, Lupin shares increased nearly 2% and touched a 52-week high of Rs 830.30 in early morning trade amid the launching of Darunavir...
Lupin Arm Receives Health Canada Approval for Spiriva Generic, Shares Up 3.12%
Shares of Lupin rose 3.12% to Rs 804 in afternoon trade on May 29, after the drugmaker announced that its subsidiary Lupin Pharma Canada has...
Lupin Extends Gains, Hits 52-Week High After Q4 Results, Shares Soar 20% in 1 Month
Shares of Lupin hit a 52-week high of Rs 796.55 in intraday trade on Monday, up 3% on the BSE, extending its gains following the...